Scintillon Institute receives BRAIN Initiative grant to expand optogenetics tools

Scintillon Institute Associate Professor Nathan Shaner, Ph.D. was awarded a U01 grant from the NIH's National Institute for Neurological Disorders and Stroke (NINDS) as part of the federal BRAIN initiative.  This grant will allow Dr. Shaner and his collaborators, Chris Moore, Ph.D.(Brown University) and Ute Hochgeschwender, M.D.(Central Michigan University), to expand the development of the non-invasive technology known as BioLuminescent OptoGenetics (BL-OG), which combines biological light production with light-sensitive proteins, allowing highly flexible manipulation of individual neurons.  

Add your reaction Share

Christopher K. Glass, M.D. Ph.D.

Tomorrow, March 3, 2017, Christopher K Glass, M.D., Ph.D., Professor of Cellular and Molecular Medicine, Professor of Medicine (UCSD) will present “Genome-wide approaches to defining microglia identity and function” at 1:15pm in the 6868 Nancy Ridge Drive seminar room.

Read more
Add your reaction Share

A new potential target for anti-aging discovered in protective protein

07 November 2016

For Immediate Release

A new potential target for anti-aging discovered in protective protein  

San Diego, CA

 

Research from the Scintillon Institute identifies a promising new target for future drug treatments for neurodegenerative disorders, including Alzheimer’s and Parkinson’s disease.  

Read more
Add your reaction Share

Michael Karin Ph.D.

Michael_Karin.jpg

Scintillon Institute proudly hosts

 

 

Michael Karin, Ph.D.

 

 Distinguished Professor of Pharmacology, Ben and Wanda Hildyard Chair for Mitochondrial and Metabolic Diseases, American Cancer Society Research Professor (UCSD)

 

“Positive and Negative Regulation of the NLRP3 Inflammasome Implications on Cancer, Aging and Neurodegeneration”

on October 24th

at 1pm

Scintillon seminar room at 6868 Nancy Ridge Drive

Read more
Add your reaction Share

Alan S. Verkman, M.D. Ph.D.

Scintillon Institute proudly hosts

 

 Alan S. Verkman, M.D. Ph.D.

 Director of the Cystic Fibrosis Research Development Program at University of California, San Francisco, former Established Investigator for the American Heart Association, and Senior Staff Member of the Cardiovascular Research Institute at University of California, San Francisco

Alan-Verkman-2.jpg

 

“Cystic fibrosis drug discovery and assay methods”

Read more
Add your reaction Share